

( (S (S-TPC-2 (NP-SBJ-1 (NP Lung-cancer mortality rates)
			(PP for
			    (NP (NP people)
				(PP under
				    (NP (NP 45 years)
					(PP of
					    (NP age)))))))
	      (VP have
		  (VP begun
		      (S (NP-SBJ *-1)
			 (VP to
			     (VP decline))))))
     ,
     (NP-SBJ federal researchers)
     (VP report
	 (SBAR 0
	       (S *T*-2)))
     .))
( (S (NP-SBJ The drop)
     (VP is
	 (ADJP-PRD particularly large
		   (PP for
		       (NP white males)))
	 ,
	 (SBAR-ADV although
		   (S (NP-SBJ (NP black males)
			      and
			      (NP white and black women))
		      (ADVP also)
		      (VP show
			  (NP lower mortality rates)))))
     .))
( (S (NP-SBJ (NP A report)
             (PP-LOC in
		     (NP (NP (NP this week 's)
			     issue)
			 (PP of
			     (NP-TTL (NP the Journal)
				     (PP of
					 (NP the National Cancer Institute)))))))
     (ADVP also)
     (VP projects
         (SBAR that
               (S (NP-SBJ-1 (NP overall U.S. mortality rates)
			    (PP from
				(NP (NP lung cancer)
				    ,
				    (NP (NP the leading cause)
					(PP of
					    (NP cancer death))))))
                  ,
                  (VP should
                      (VP begin
                          (S (NP-SBJ *-1)
                             (VP to
                                 (VP drop)))
			  (PP-TMP in
				  (NP several years))
			  (SBAR-ADV if
				    (S (NP-SBJ-2 cigarette smoking)
				       (VP continues
					   (S (NP-SBJ *-2)
					      (VP to
						  (VP abate)))))))))))
     .))
( (S (NP-SBJ (NP The report)
             ,
             (SBAR (WHNP-1 which)
                   (S (NP-SBJ *T*-1)
                      (VP comes
			  (SBAR-TMP (NP 25 years)
				    after
				    (S (NP-SBJ the U.S. Surgeon General)
				       (VP issued
					   (NP (NP a report)
					       (VP warning
						   (PP-CLR against
							   (NP (NP the dangers)
							       (PP of
								   (NP smoking))))))))))))
             ,)
     (VP is
         (NP-PRD (NP the strongest indication)
                 (PP-TMP to
			 (NP date))
                 (SBAR that
                       (S (NP-SBJ (NP the reduction)
                                  (PP-LOC in
					  (NP smoking)))
                          (VP is
                              (VP leading
                                  (PP-DIR to
					  (NP (NP lower death rates)
					      (PP from
						  (NP lung cancer))))))))))
     .))
( (SINV ``
	(S-TPC-2 (NP-SBJ (SBAR (WHNP-1 What)
			       (S (NP-SBJ this)
				  (VP is
				      (VP saying
					  (NP *T*-1))))))
		 (VP is
		     (SBAR-PRD that
			       (S (NP-SBJ (NP the surgeon general 's)
					  message)
				  (VP is
				      (VP having
					  (NP an impact)))))))
	, ''
	(VP said
	    (S *T*-2))
	(NP-SBJ (NP Melvyn Tockman)
		,
		(NP (NP an epidemiologist)
		    (PP-LOC at
			    (NP (NP the Johns Hopkins School)
				(PP of
				    (NP (NP Hygiene)
					and
					(NP Public Health)))
				(PP-LOC in
					(NP Baltimore))))))
	.))
( (S (NP-SBJ The National Cancer Institute report)
     (VP compares
         (NP (NP mortality rates)
             (PP of
                 (NP (NP two groups)
                     (PP of
                         (NP (NP people)
                             (PP between
                                 (NP (NP the ages)
                                     (PP of
                                         (NP 35 and 44))))))
		     (ADJP (NP a decade)
			   apart)))))
     .))
( (S (S (NP-SBJ (NP The death rate)
                (PP from
                    (NP (NP lung cancer)
                        (PP of
                            (NP (NP white males)
                                (VP aged
                                    (NP *)
                                    (NP (NP 35)
                                        (PP to
                                            (NP 44))))))))
		(PP-TMP in
			(NP the mid-1970s)))
	(VP was
            (NP-PRD (NP 13.4)
                    (PP per
                        (NP 100,000)))))
     , but
     (S (NP-SBJ (NP the mortality rate)
                (PP of
                    (NP the same age group))
		(PP-TMP in
			(NP the mid-1980s)))
	(VP was
            (NP-PRD (NP 9.6)
                    ,
                    (NP (NP a decline)
                        (PP of
                            (NP 28.7 %))))))
     .))
( (S (S-ADV (NP-SBJ *-1)
	    (VP Measured
		(NP the same way)))
     ,
     (NP-SBJ-1 (NP the decline)
	       (PP for
		   (NP black males)))
     (VP was
	 (NP-PRD 14.2 %))
     .))
( (S (NP-SBJ (NP The drop)
             (PP-LOC in
		     (NP (NP mortality rates)
			 (PP for
			     (NP women)))))
     (VP was
	 (UCP-PRD (ADJP less steep)
		  --
		  (NP (NP (NP 8.9 %)
			  (PP for
			      (NP blacks)))
		      and
		      (NP (NP 5.3 %)
			  (PP for
			      (NP whites))))))
     .))
( (S (NP-SBJ (NP The study) 
	     ,
             (PP by
                 (NP (NP Susan Devesa)
                     ,
                     (NP William Blot)
                     and
                     (NP Joseph Fraumeni)))
             (PP of
                 (NP (NP the institute 's)
                     staff))
             ,)
     (ADVP also)
     (VP shows
         (SBAR that
               (S (NP-SBJ (NP (NP the incidence)
                              (PP of
                                  (NP lung cancer)))
                          (CONJP as well as)
                          (NP the death rate))
                  (VP declined
                      (PP-TMP over
			      (NP the decade))
                      (PP for
                          (NP (NP all groups)
                              (PP-LOC in
				      (NP the 35-44 age bracket))
                              ,
                              (PP except
                                  (NP black men))))))))
     .))
( (S (SBAR-ADV Although
	       (S (NP-SBJ lung-cancer mortality rates)
		  (VP are
		      (VP increasing
			  (PP for
			      (NP (NP the nation)
				  (PP as
				      (NP a whole))))))))
     ,
     (NP-SBJ the report)
     (VP projects
         (SBAR that
               (S (NP-SBJ-1 death rates)
		  (VP will
		      (VP begin
			  (S (NP-SBJ *-1)
			     (VP to
				 (VP (VP decline
					 (PP-TMP-2 in
						   (NP the 1990s))
					 (PP-3 for
					       (NP men)))
				     and
				     (VP (PP-TMP=2 after
						   (NP the year 2000))
					 (PP=3 for
					       (NP women)))))))))))
     .))
( (S (NP-SBJ-1 Lung-cancer mortality rates)
     (VP (VP increase
	     (PP with
		 (NP age)))
	 and
	 (VP are
	     (VP continuing
		 (S (NP-SBJ *-1)
		    (VP to
			(VP rise
			    (PP for
				(NP (NP all age groups)
				    (PP over
					(NP 55))))
			    ,
			    (PP with
				(NP (NP sharp increases)
				    (PP for
					(NP (NP everybody)
					    but
					    (NP white men)))))))))))
     .))
( (S But
     (NP-SBJ (NP Dr. Fraumeni)
             ,
             (NP (NP one)
                 (PP of
                     (NP (NP the authors)
                         (PP of
                             (NP the report)))))
             ,)
     (VP said
	       ``
	       (S (NP-TPC-1 (NP the declining rates)
			    (SBAR (WHNP-3 0)
				  (S (NP-SBJ we)
				     (VP 're
					 (VP seeing
					     (NP *T*-3)
					     (PP for
						 (NP younger people)))))))
                  (NP-SBJ we)
		  (VP believe
		      (S (NP-SBJ *T*-1) 
			 (VP may
			     (S (NP-SBJ *)
				(VP be
				    (NP-PRD (NP a harbinger)
					    (PP of
						(NP (NP declining mortality)
						    (PP-TMP in
							    (NP the future))))))))))))
     . ''))
( (S (ADVP However)
     ,
     (NP-SBJ he)
     (VP stressed
         (SBAR that
               (S (NP-SBJ the improvement)
                  (VP depends
                      (PP-LOC-CLR on
				  (NP (NP a continued reduction)
				      (PP-LOC in
					      (NP smoking))))))))
     .))
( (S ``
     (S-TPC-2 (SBAR-ADV (ADVP Even)
			though
			(S (NP-SBJ (NP these favorable trends)
				   (PP-LOC in
					   (NP lung-cancer mortality)))
			   (VP affect
			       (NP all sex and race groups))))
	      ,
	      (NP-SBJ-1 they)
	      (VP ca n't
		  (VP be
		      (VP taken
			  (NP *-1) 
			  (PP-CLR for
				  (ADJP granted))))))
     , ''
     (NP-SBJ the report)
     (VP says
	 (S *T*-2))
     .))
( (S ``
     (NP-SBJ Smoking prevention programs)
     (VP should
         (VP reach
             (NP (NP (NP larger segments)
                     (PP of
                         (NP the population)))
                 ,
                 (NP especially children , adolescents and minorities))))
     . ''))
( (S (NP-SBJ (NP An editorial)
             (PP-LOC in
		     (NP the NCI Journal)))
     (VP says
         (SBAR 0
               (S (NP-SBJ (NP the report)
                          (PP of
                              (NP (NP declining lung-cancer mortality ``)
                                  (PP-LOC among
					  (NP (NP young men and women)
					      (PP-LOC in
						      (NP the U.S.)))))))
                  (VP indicates
                      (SBAR that
                            (S (NP-SBJ we)
			       (ADVP finally)
			       (VP may
				   (VP be
				       (VP winning
					   (NP the battle)
					   --
					   (FRAG (NP this)
						 (PP-LOC (ADVP even)
							 in
							 (NP (NP a country)
							     (SBAR (WHADVP-1 where)
								   (S (NP-SBJ the tobacco industry)
								      (VP spends
									  (NP (NP (QP over $ 2 billion) *U*)
									      (NP-ADV a year))
									  (PP for
									      (NP (NP promotion)
										  (PP of
										      (NP (NP the addictive habit)
											  (PP of
											      (NP smoking))))))
									  (ADVP-LOC *T*-1))))))))))))))))
     . ''))
( (S But
     (NP-SBJ (NP the editorial)
             ,
             (PP by
                 (NP (NP Jan Stjernsward)
                     (PP of
                         (NP the World Health Organization))))
             ,)
     (VP notes
         (SBAR that
               (S (NP-SBJ tobacco consumption 
			  and 
			  lung-cancer mortality 
			  rates) 
                  (VP are
                      (VP rising
                          (PP-LOC in
				  (NP developing countries)))))))
     .))
( (S-3 ``
       (NP-SBJ-1 Non-smoking)
       (VP should
	   (VP be
	       (VP established
		   (NP *-1)
		   (PP-CLR as
			   (NP (NP the norm)
			       (PP of
				   (NP social behavior))
			       ''
			       (PP-LOC around
				       (NP the world)))))))
       (PRN ,
	    (S (NP-SBJ the editorial)
	       (VP says
		   (SBAR 0
			 (S *T*-3))))
	    ,)
       (PP through
	   (NP (NP the enactment)
	       (PP of
		   (NP (NP laws)
		       (SBAR (WHNP-2 that)
			     (S (NP-SBJ *T*-2)
				(VP (VP limit
					(NP advertising))
				    ,
				    (VP boost
					(NP tobacco prices))
				    and
				    (VP promote
					(NP anti-smoking education)))))))))
       .))
( (S (S (NP-SBJ-1 *-2)
	(VP Asked
	    (NP *-1)
	    (PP for
		(NP comment))))
     ,
     (NP-SBJ-2 (NP Walker Merryman)
	       ,
	       (NP (NP a vice president)
		   (PP of
		       (NP the Tobacco Institute))))
     ,
     (VP said
	 (SBAR 0
	       (S (NP-SBJ new efforts
			  (S (NP-SBJ *)
			     (VP to
				 (VP restrict
				     (NP tobacco advertising)
				     (PP-LOC in
					     (NP the U.S.))))))
		  (VP could
		      (VP violate
			  (NP (NP the First Amendment protection)
			      (PP of
				  (NP free speech))))))))
     .))
( (S (PP According
         (PP to
             (NP the American Cancer Society)))
     ,
     (NP-SBJ smoking)
     (VP is
	 (ADJP-PRD responsible
		   (PP for
		       (NP (NP (NP 85 %)
			       (PP of
				   (NP (NP the lung-cancer cases)
				       (PP among
					   (NP men)))))
			   and
			   (NP (NP 75 %)
			       (PP among
				   (NP women)))))))
     .))
( (S (NP-SBJ The NCI report)
     (VP attributes
         (NP (NP the differences)
             (PP-LOC in
		     (NP mortality rates))
             (PP by
                 (NP race)))
         (PP-CLR to
		 (NP different smoking patterns)))
     .))
( (S (NP-SBJ (NP A higher proportion)
             (PP of
                 (NP black men))
             (PP *ICH*-3))
     (VP smoke
	 (PP-3 than
	       (NP white men))) 
     .))
( (S (SBAR-ADV While 
	       (S (NP-SBJ (NP (ADJP nearly equal)
			      percentages)
			  (PP of
			      (NP black and white women)))
		  (ADVP-TMP currently)
		  (VP smoke)))
     ,
     (PP-LOC in
	     (NP both sexes))
     (NP-SBJ (NP more whites)
	     (PP *ICH*-4))
     (VP have
	 (VP given (PRT up)
	     (NP smoking)
	     (PP-4 than
		   (NP blacks))))
     .))
( (S (PP In
         (S-NOM (NP-SBJ *)
		(VP comparing
		    (NP (NP changes)
			(PP-LOC in
				(NP mortality rates))
			(PP-TMP over
				(NP the past decade))))))
     ,
     (NP-SBJ the NCI study)
     (VP looked
         (ADVP only)
         (PP-CLR at
		 (NP blacks and whites)))
     .))
( (S (S (NP-SBJ-2 (NP Asians)
		  and
		  (NP native Americans))
        (VP were n't
            (VP studied
		(NP *-2))))
     ;
     (S (NP-SBJ-1 Hispanics)
        (VP were
            (VP included
                (NP *-1)
                (PP-CLR with
			(NP whites)))))
     .))
( (NP (NP Recent changes)
      (PP-LOC in
	      (NP (NP average annual age-specific lung-cancer rates)
		  (PP per
		      (NP 100,000 population))
		  (PP by
		      (NP race and sex))))
      .))
( (NP-HLN White Males))
( (NP-HLN White Females))
( (NP-HLN Black Males))
( (NP-HLN Black Females))
